Biogen Acquires Apellis for $5.6B
Biogen acquired Apellis in May 2026 to expand Biogen’s presence in immunology and rare diseases.
Beam Therapeutics Enters into $500 Million Financing Agreement with Investment Firm Sixth Street
Beam will use the funding to further develop risto-cel.
Penn Engineering researchers are developing new genetic technologies designed to make treating complex diseases simpler
In the field of bioengineering, Penn researchers are leveraging AI to improve gene editing tools and genetic engineering.
Penn Faculty Weighs in On the Future of American Science
John Wherry, PhD, the Richard and Barbara Schiffrin President's Distinguished Professor at Penn Medicine, explains how decades of federal funding for basic science enabled breakthroughs.
Penn Partners in New National Science Foundation AI Institute for Human-AI Cooperation
The institute will bring together more than 40 partners across academia, industry, government, healthcare, and nonprofit organizations to transform the role of AI in healthcare.
PA State Budget Passes with $125 million Investment in Pennsylvania’s Life Sciences Industry
The budget includes the Innovate in PA 2.0 Program, which will provide capital for startups, fund clinical trials for life sciences and improve the Commonwealth's innovation network.
CAR T Cell Therapy for Lymphoma Leads to 10 Year Remissions for Patients
The follow-up study of patients ten years later showed promising results.
ARPA-H Awards $43 million to Philadelphia Gene Therapy Researchers to Advance Rare Disease Treatments
Learn more about the recipients.
BioAdvance Capital Invests in Penn Life Sciences Startups
These investments will support the startups in further developing their treatments and technologies.
Network Bio Launches with $50 million in Funding to Create a Research Network of Large Biobanks to Drive AI Medical Research
Several U.S. Academic Medical Centers, including Penn Medicine, have partnered with Network Bio to generate large-scale multi-omic and multi-modal datasets.